Showing posts with label Medical Devices. Show all posts
Showing posts with label Medical Devices. Show all posts

Thursday, 21 July 2016

Innovative Biopsy Devices Identify Cancer Cells at its Early Stage

https://blog.alliedmarketresearch.com - Today, biopsy devices market players are seen introducing innovative devices that can identify cancer cells at an early stage. 

With the advancements of modern science, and emergence of bio-psycho-socio-therapeutic model, there has been a growing demand for obtaining accurate therapeutic results, say research analysts at Allied Market Research (AMR). Optimal therapeutic result with minimal damage is what many prominent players such as UAB focusing on, highlight AMR researchers. Earlier, oncologists depended greatly on sophisticated and complex imaging devices and biopsies to detect diseases such as cancer in symptomatic patients. In most cases, when detected the disease is often at an advanced stage, which makes it tougher to cure or treat. Therefore, to enhance the clinical results, scientists are concentrating on ways to detect cancer sooner. Such efforts have encouraged innovative discoveries in the biopsy devices market.

CT Guided Device Discovery Brings Hope for Radiology Department


There has been an increasing demand for a device that can aid Interventional radiologists to carry out “Computed Tomography (CT)” directed biopsy safely. In a recent incident a group of engineering students from the famous Sultan Qaboos University and medical specialists from the Oman Medical Specialty Board created history by inventing a similar CT guided device. Echoing their sentiments about the device the team said “We called our device the Painless CT-guided Biopsy Device.”

Computed Tomography guided biopsy is a procedure by which Interventional radiologists can obtain a sample of the tissues from a human body.  The tissue sample is then tested in a histopathology laboratory to get the final diagnosis results. So far, the process was performed manually. Besides this, the traditional method also carried greater risk for medical practitioners and patients and is time-consuming. But, not anymore! The team behind this innovative equipment is determined to demonstrate it at various local conferences and international events and exhibitions. Such discoveries are expected to drive in huge investment towards R&D in the biopsy devices market.

Robotic Surgeon is here to Detect Your Cancer Cells


There has been a growing speculation about surgeons being assisted by robots to detect cancerous tissues. While many doubted the capability of these knives to sniff out the cancer cells, iKnife - an intelligent knife - shows its dexterity is beyond normal human potentiality. Developed by a group of scientists at “Imperial College London”, the device is undergoing clinical trials as a part of the institute’s plans to “roboticise” medical surgery.

iKnife can easily detect the smoke as it burns through human tissue. This enables doctors to identify if the cells are cancerous. The team behind the discovery explains that the optical biopsy device has the power to sniff the cancer cells, and is an imaging tool that overlays traditional x-ray and MRI images onto real – time images to guide surgeons. Guang-Zhong Yang, a professor and director at the reputed Hamlyn Centre, Imperial College said “We are entering a new age of precision surgery.” Yang added “We want to enhance surgeons with robots that give them almost superhuman powers to image and diagnose damaged tissues, and the dexterity to repair them.”

Monday, 11 July 2016

Congestive Heart Failure (CHF) Treatment Devices Market

http://www.dicardiology.com - Implantable cardioverter defibrillators to account for majority of the growth thanks to aging population with higher prevalence of heart arrhythmia issues


June 28, 2016 — A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatment Devices Market," projects that the world market would reach $14.8 billion by 2022, at a compound annual growth rate (CAGR) of 5.5 percent from 2016 to 2022. The implantable cardioverter-defibrillator (ICD) segment is expected to dominate the world CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the world CHF treatment devices.


FDA Approves Auris Robotic Endoscopy System

Picture: Artist’s illustration from Auris’ patent application

http://roboticsandautomationnews.com - Though Auris has not unveiled its much awaited endoscopy system, the recent approval from the Food and Drug Association has got many industry experts and principal investigator sharing their opinion

How many of us would actually trust a robotic surgeon operating on us? Not many. But the new precise and dexterous medical robot approved by the FDA shows they could soon take over the operation theater.